Overview

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

a study to investigate the pharmacokinetic characteristics and safety/tolerability according to formulations of CKD-386 in healthy male volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical